Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina
Masanobu Ishii(Kumamoto Health Science University), Hisao Ogawa(Kumamoto University Hospital), Kenichi Tsujita(Kumamoto University), Kenji Sakamoto(Kumamoto University), Kunihiko Matsui(Kumamoto University), Koichi Sugamura(Jikei University School of Medicine), Tomoko Tanaka(Kumamoto University), Eiichiro Yamamoto(Kumamoto University), Seiji Hokimoto(Kumamoto University), Sunao Kojima(Kumamoto University), Koichi Kaikita(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Koji Sato(Kumamoto University), Yasuhiro Izumiya(Kumamoto University), Hirofumi Soejima(Kumamoto Health Science University)
Cited by 81
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449